UOC
OREX

UBS O'Connor’s Orexigen Therapeutics, Inc. OREX Stock Holding History

UBS O'Connor’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-33,333
Closed – – 420
2018
Q1 		$0 Hold
33,333
– – ﹤0.01% 435
2017
Q4 		$0 Hold
33,333
– – ﹤0.01% 442
2017
Q3 		$0 Hold
33,333
– – ﹤0.01% 521
2017
Q2 		$0 Hold
33,333
– – ﹤0.01% 553
2017
Q1 		$0 Buy
+33,333
New +$132K ﹤0.01% 533

Other funds holding OREX

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

UBS O'Connor's OREX Position: Q2 2018 in Review

UBS O'Connor sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 33,333 shares.

UBS O'Connor first reported a position in OREX in Q1 2017 and held it in 5 quarters. The position peaked at $0 in Q1 2018. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

  • UBS O'Connor reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • UBS O'Connor sold 33,333 Orexigen Therapeutics, Inc. shares in Q2 2018.
  • UBS O'Connor first reported a position in Orexigen Therapeutics, Inc. in Q1 2017 and held it in 5 quarters.
  • UBS O'Connor's Orexigen Therapeutics, Inc. position peaked at $0 in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on UBS O'Connor's 13F filing for Q2 2018, filed 14 Aug 2018.